	Capital Social Ordinario		Fecha
Acadia Pharmaceuticals	USD 169.18M	470K	2025-12
Alnylam Pharmaceuticals	USD 132.38M	585K	2025-12
Amgen	USD 539M	1000K	2025-12
BioCryst Pharmaceuticals	USD 1.9M	3K	2023-09
Biogen	USD 146.7M	200K	2025-09
BioMarin Pharmaceutical	USD 192.3M	201K	2025-12
Cytokinetics	USD 122.26M	145K	2025-12
Daiichi Sankyo	JPY 1.85B	9K	2025-12
Enanta Pharmaceuticals	USD 212K	1000	2023-12
Esperion Therapeutics	USD 112K	11K	2023-09
Gilead Sciences	USD 1.24B	1000K	2025-12
Incyte	USD 198.46M	2.33M	2025-12
Ionis Pharmaceuticals	USD 161.97M	836K	2025-12
Ironwood Pharmaceuticals	USD 160K	0	2024-12
Karyopharm Therapeutics	USD 13K	0	2024-09
Novartis	USD 1.94B	23.4M	2025-06
Pfizer	USD 5.69B	1000K	2025-09
PTC Therapeutics	USD 81.47M	1.54M	2025-12
Puma Biotechnology	USD 5K	0	2024-06
Roche Holding	CHF 795.62M	699.54K	2025-12
Sarepta Therapeutics	USD 104.96M	196K	2025-12
TG Therapeutics	USD 155.21M	2.81M	2025-09
Ultragenyx Pharmaceutical	USD 96.44M	88K	2025-09
Vertex Pharmaceuticals	USD 254M	0	2025-12
Xencor	USD 71.87M	529K	2025-12

PTC Therapeutics Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.